Viewing Study NCT04416568


Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2025-12-24 @ 6:29 PM
Study NCT ID: NCT04416568
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2020-06-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
Sponsor: Dana-Farber Cancer Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 20-041
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View